shot-button
Ganesh Chaturthi Ganesh Chaturthi
Home > News > India News > Article > Suspected monkeypox infection reported from Malappuram in Kerala samples sent for testing

Suspected monkeypox infection reported from Malappuram in Kerala, samples sent for testing

Updated on: 17 September,2024 11:17 AM IST  |  Malappuram
PTI |

A suspected case of monkeypox infection has been reported from Malappuram district of Kerala after a man who recently returned from abroad showed symptoms of the disease.

Suspected monkeypox infection reported from Malappuram in Kerala, samples sent for testing

Representative Image

Listen to this article
Suspected monkeypox infection reported from Malappuram in Kerala, samples sent for testing
x
00:00

A suspected case of monkeypox infection has been reported from Malappuram district of Kerala after a man who recently returned from abroad showed symptoms of the disease.


A district health official said that the patient arrived in Kerala a few days ago and, after falling sick, was first admitted to a private hospital.



"From there he was admitted to the Manjeri Medical College. On suspecting that it might be a case of monkeypox, we sent his samples to the Kozhikode Medical College for testing. The results are awaited," the official said.


A new case of monkeypox (Mpox) was reported last week from the national capital after a 26-year-old resident of Haryana's Hisar tested positive for the virus and was admitted to Delhi government-run LNJP Hospital.

The Union Health Ministry had termed it an isolated case, similar to the earlier 30 cases reported in India from July 2022 onwards and said that it was not part of the current public health emergency reported by WHO which is regarding clade 1 of mpox, it underlined.

The 26-year-old Hisar native tested positive for mpox virus of the West African clade-2, it had said.

The World Health Organisation (WHO) last month declared mpox a Public Health Emergency of International Concern (PHEIC) for the second time in view of its prevalence and spread across many parts of Africa.

Mpox infections are generally self-limiting, lasting between two and four weeks, and its patients usually recover with supportive medical care and management. It is transmitted through prolonged and close contact with an infected patient.

It typically manifests itself with fever, rash and swollen lymph nodes and may lead to a range of medical complications.

The suspected monkeypox case in Kerala has been reported in the wake of containment zones being established in the Malappuram district after the recent death of a 24-year-old due to Nipah infection.

The government on Sunday confirmed that the man who died on September 9, was infected with Nipah virus.

A boy from Malappuram, who was undergoing treatment for Nipah infection, died on July 21. It was the first confirmed case of Nipah infection in the state this year.

Nipah outbreaks have been reported in Kozhikode district in 2018, 2021 and 2023 and in Ernakulam district in 2019.

The presence of Nipah virus antibodies had been detected in bats in Kozhikode, Wayanad, Idukki, Malappuram and Ernakulam districts.

This story has been sourced from a third party syndicated feed, agencies. Mid-day accepts no responsibility or liability for its dependability, trustworthiness, reliability and data of the text. Mid-day management/mid-day.com reserves the sole right to alter, delete or remove (without notice) the content in its absolute discretion for any reason whatsoever

"Exciting news! Mid-day is now on WhatsApp Channels Subscribe today by clicking the link and stay updated with the latest news!" Click here!

Register for FREE
to continue reading !

This is not a paywall.
However, your registration helps us understand your preferences better and enables us to provide insightful and credible journalism for all our readers.

Mid-Day Web Stories

Mid-Day Web Stories

This website uses cookie or similar technologies, to enhance your browsing experience and provide personalised recommendations. By continuing to use our website, you agree to our Privacy Policy and Cookie Policy. OK